TipRanks
Genor Biopharma Holdings Limited (DE:67N0)
FRANKFURT:67N0
Germany Market
67N0
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports

Genor Biopharma Holdings Limited (67N0) Ratios

0 Followers

Genor Biopharma Holdings Limited Ratios

DE:67N0's free cash flow for Q4 2025 was ¥0.68. For the 2025 fiscal year, DE:67N0's free cash flow was decreased by ¥ and operating cash flow was ¥0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.00 1.00 8.74 5.41 6.61
Quick Ratio
 0.78 0.80 4.21 5.38 6.42
Cash Ratio
 0.47 0.48 8.67 5.08 6.10
Solvency Ratio
 0.28 0.25 4.57 -2.38 -2.18
Operating Cash Flow Ratio
 0.13 0.20 -1.00 -1.85 -2.22
Short-Term Operating Cash Flow Coverage
 0.23 0.42 0.00 0.00 0.00
Net Current Asset Value
¥ -172.22M¥ -551.23M¥ 929.24M¥ 984.95M¥ 1.41B
Leverage Ratios
Debt-to-Assets Ratio
 0.19 0.23 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 0.30 0.39 <0.01 <0.01 0.02
Debt-to-Capital Ratio
 0.23 0.28 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.09 0.00 0.00 0.00
Financial Leverage Ratio
 1.53 1.71 1.12 1.22 1.17
Debt Service Coverage Ratio
 0.73 0.68 2.92 0.00 -235.95
Interest Coverage Ratio
 4.20 3.86 2.54 0.00 -275.28
Debt to Market Cap
 0.40 0.32 0.00 0.00 0.00
Interest Debt Per Share
 0.70 1.00 0.55 0.01 0.06
Net Debt to EBITDA
 0.24 0.45 -1.14 2.10 2.31
Profitability Margins
Gross Profit Margin
62.60%65.18%64.61%0.00%93.83%
EBIT Margin
26.67%25.56%25.85%0.00%-4579.24%
EBITDA Margin
31.44%35.37%33.48%0.00%-4242.32%
Operating Profit Margin
26.67%25.56%25.85%0.00%-4934.75%
Pretax Profit Margin
15.64%19.95%18.95%0.00%-4597.16%
Net Profit Margin
12.09%16.05%15.23%0.00%-4584.46%
Continuous Operations Profit Margin
12.09%16.05%15.23%0.00%-4584.46%
Net Income Per EBT
77.33%80.45%80.39%99.54%99.72%
EBT Per EBIT
58.63%78.06%73.31%95.26%93.16%
Return on Assets (ROA)
7.07%6.56%32.61%-46.61%-34.53%
Return on Equity (ROE)
10.99%11.23%36.52%-56.73%-40.52%
Return on Capital Employed (ROCE)
22.87%15.69%61.12%-58.42%-42.39%
Return on Invested Capital (ROIC)
13.87%10.13%49.12%-58.07%-42.12%
Return on Tangible Assets
16.54%14.60%35.36%-50.45%-37.42%
Earnings Yield
15.15%9.60%50.40%-125.65%-61.66%
Efficiency Ratios
Receivables Turnover
 24.46 4.26 0.00 0.00 0.00
Payables Turnover
 11.38 2.91 11.80 0.00 <0.01
Inventory Turnover
 3.05 2.17 1.77 0.00 0.02
Fixed Asset Turnover
 10.45 7.96 474.39 0.00 0.08
Asset Turnover
 0.58 0.41 2.14 0.00 <0.01
Working Capital Turnover Ratio
 -1.25K 5.77 2.82 0.00 <0.01
Cash Conversion Cycle
 102.70 128.32 175.57 0.00 -31.47K
Days of Sales Outstanding
 14.92 85.75 0.00 0.00 0.00
Days of Inventory Outstanding
 119.84 168.04 206.51 0.00 17.60K
Days of Payables Outstanding
 32.06 125.48 30.94 0.00 49.07K
Operating Cycle
 134.76 253.80 206.51 0.00 17.60K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.13 0.27 -0.24 -0.84 -1.15
Free Cash Flow Per Share
 0.11 0.24 -0.24 -0.84 -1.17
CapEx Per Share
 0.02 0.03 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.82 0.89 1.01 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 2.80 4.80 -77.79 -411.14 -44.59
Capital Expenditure Coverage Ratio
 5.63 9.47 -77.79 -411.14 -44.59
Operating Cash Flow Coverage Ratio
 0.22 0.30 -133.90 -59.42 -20.21
Operating Cash Flow to Sales Ratio
 0.07 0.17 -0.04 0.00 -36.25
Free Cash Flow Yield
7.51%8.96%-14.81%-79.40%-49.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 4.63 11.72 1.98 -0.80 -1.62
Price-to-Sales (P/S) Ratio
 0.79 1.67 0.30 0.00 74.35
Price-to-Book (P/B) Ratio
 0.71 1.17 0.72 0.45 0.66
Price-to-Free Cash Flow (P/FCF) Ratio
 13.32 11.17 -6.75 -1.26 -2.01
Price-to-Operating Cash Flow Ratio
 11.00 9.99 -6.84 -1.26 -2.05
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.16 -0.02 0.10 0.09
Price-to-Fair Value
 0.71 1.17 0.72 0.45 0.66
Enterprise Value Multiple
 2.77 5.18 -0.24 1.13 0.56
Enterprise Value
 3.10B 4.94B -223.46M -621.64M -375.63M
EV to EBITDA
 2.77 5.18 -0.24 1.13 0.56
EV to Sales
 0.87 1.83 -0.08 0.00 -23.58
EV to Free Cash Flow
 14.58 12.23 1.81 1.46 0.64
EV to Operating Cash Flow
 11.99 10.94 1.83 1.46 0.65
Tangible Book Value Per Share
 0.25 0.13 2.05 2.13 3.26
Shareholders’ Equity Per Share
 1.99 2.30 2.24 2.35 3.57
Tax and Other Ratios
Effective Tax Rate
 0.23 0.20 0.20 <0.01 <0.01
Revenue Per Share
 1.78 1.61 5.38 0.00 0.03
Net Income Per Share
 0.22 0.26 0.82 -1.33 -1.45
Tax Burden
 0.77 0.80 0.80 1.00 1.00
Interest Burden
 0.59 0.78 0.73 1.10 1.00
Research & Development to Revenue
 0.06 0.07 0.05 0.00 36.65
SG&A to Revenue
 0.30 0.33 0.34 0.00 8.42
Stock-Based Compensation to Revenue
 0.01 0.02 <0.01 0.00 3.03
Income Quality
 0.52 0.91 2.38 0.63 0.79
Currency in CNY